The role of CRF receptors in anxiety and depression: Implications of the novel CRF1 agonist cortagine

Neuroscience and Biobehavioral Reviews

Volumn 29, Issue 8, 2005, Pages 1323-1333

  Todorovic, Cedomir ^a   Jahn, Olaf ^a   Tezval, Hossein ^a   Hippel, Cathrin ^a   Spiess, Joachim ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Anxiety; Cortagine; Corticotropin releasing factor receptors; Depression; Elevated plus maze; Forced swim test

Indexed keywords

2 [N (2 BROMO 4 ISOPROPYLPHENYL) N ETHYLAMINO] 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 6 METHYLPYRIMIDINE; 3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; ALPRAZOLAM; ANXIOLYTIC AGENT; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTAGINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1 AGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; HORMONE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANXIETY; BEHAVIOR; CONFERENCE PAPER; DEPRESSION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SPECIFICITY; FORCED SWIMMING TEST; HUMAN; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; STRESS; TRANQUILIZING ACTIVITY; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; HIPPOCAMPUS; HUMANS; MICE; MICE, KNOCKOUT; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECOMBINANT FUSION PROTEINS;

EID: 26844559364     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2005.04.014     Document Type: Conference Paper

References (76)

1. L. Arborelius, M.J. Owens, P.M. Plotsky, and C.B. Nemeroff The role of corticotropin-releasing factor in depression and anxiety disorders J. Endocrinol. 160 1999 1 12
2. L. Arborelius, K.H. Skelton, K.V. Thrivikraman, P.M. Plotsky, D.W. Schulz, and M.J. Owens Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat J. Pharmacol. Exp. Ther. 294 2000 588 597
3. T.L. Bale, and W.W. Vale Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses J. Neurosci. 23 2003 5295 5301
4. T.L. Bale, A. Contarino, G.W. Smith, R. Chan, L.H. Gold, P.E. Sawchenko, G.F. Koob, W.W. Vale, and K.F. Lee Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress Nat. Genet. 24 2000 410 414
5. D.P. Behan, S.C. Heinrichs, J.C. Troncoso, X.J. Liu, C.H. Kawas, N. Ling, and E.B. De Souza Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease Nature 378 1995 284 287
6. M. Beyermann, S. Rothemund, N. Heinrich, K. Fechner, J. Furkert, M. Dathe, R. Winter, E. Krause, and M. Bienert A role for a helical connector between two receptor binding sites of a long-chain peptide hormone J. Biol. Chem. 275 2000 5702 5709
7. O. Brauns, T. Liepold, J. Radulovic, and J. Spiess Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helical CRF: significance for behavioral experiments Neuropharmacology 40 2001 507 516
8. D.J. Chadwick, J. Marsh, and K. Ackrill Corticotropin-releasing factor Ciba Foundation Symposium 172 1993 Wiley London
9. S. Chaki, A. Nakazato, L. Kennis, M. Nakamura, C. Mackie, M. Sugiura, P. Vinken, D. Ashton, X. Langlois, and T. Steckler Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450 Eur. J. Pharmacol. 485 2004 145 158
10. D.T. Chalmers, T.W. Lovenberg, and E.B. De Souza Localization of novel corticotropin-releasing factor receptor (CRF-2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF-1 receptor mRNA expression J. Neurosci. 15 1995 6340 6350
11. C.M. Contreras, M. Molina, M. Saavedra, and L. Martinez-Mota Lateral septal neuronal firing rate increases during proestrus-estrus in the rat Physiol. Behav. 68 2000 279 284
12. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245
13. A. Desmedt, R. Garcia, and R. Jaffard Differential modulation of changes in hippocampal-septal synaptic excitability by the amygdala as a function of either elemental or contextual fear conditioning in mice J. Neurosci. 18 1998 480 487
14. M.J. Detke, S. Wieland, and I. Lucki Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists Psychopharmacology 119 1995 47 54
15. A.J. Dunn, and C.W. Berridge Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15 1990 71 100
16. K. Eckart, O. Jahn, J. Radulovic, H. Tezval, L. van Werven, and J. Spiess A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists Proc. Natl Acad. Sci. USA 98 2001 11142 11147
17. K. Eckart, O. Jahn, J. Radulovic, M. Radulovic, T. Blank, O. Stiedl, O. Brauns, H. Tezval, T. Zeyda, and J. Spiess Pharmacology and biology of corticotropin-releasing factor (CRF) receptors Recept. Channels 8 2002 163 177
18. G. Griebel, G. Perrault, and D.J. Sanger Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone Psychopharmacology 138 1998 55 66
19. G. Griebel, J. Simiand, R. Steinberg, M. Jung, D. Gullly, P. Roger, M. Geslin, B. Scatton, J.P. Maffrand, and P. Soubrie 4-(2-Chloro-4-methoxy-5- methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4 methylphenyl)ethyl]5-methyl-N- (2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders J. Pharmacol. Exp. Ther. 301 2002 333 345
20. D.A. Gutman, and C.B. Nemeroff Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies Physiol. Behav. 79 2003 471 478
21. D.A. Gutman, M.J. Owens, K.H. Skelton, K.V. Thrivikraman, and C.B. Nemeroff The corticotropin-releasing factor 1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress J. Pharmacol. Exp. Ther. 304 2003 874 880
22. K.E. Habib, K.P. Weld, K.C. Rice, J. Pushkas, M. Champoux, S. Listwak, E.L. Webster, A.J. Atkinson, J. Schulkin, C. Contoreggi, G.P. Chrousos, S.M. McCann, S.J. Suomi, J.D. Higley, and P.W. Gold Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates Proc. Natl Acad. Sci. USA 97 2000 6079 6084
23. S.E. Hammack, K.J. Richey, M.J. Schmid, M.L. LoPresti, L.R. Watkins, and S.F. Maier The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress J. Neurosci. 22 2002 1020 1026
24. S.E. Hammack, M.J. Schmid, M.L. LoPresti, A. Der-Avakian, M.A. Pellymounter, A.C. Foster, L.R. Watkins, and S.F. Maier Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress J. Neurosci. 23 2003 1019 1025
25. S.C. Heinrichs, J. Lapsansky, T.W. Lovenberg, E.B. De Souza, and D.T. Chalmers Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior Regul. Pept. 71 1997 15 21
26. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
27. S.Y. Hsu, and A.J.W. Hsueh Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor Nat. Med. 7 2001 605 611
28. O. Jahn, H. Tezval, L. van Werven, K. Eckart, and J. Spiess Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity Neuropharmacology 47 2004 233 242
29. I.J. Karolyi, H.L. Burrows, T.M. Ramesh, M. Nakajima, J.S. Lesh, E. Seong, S.A. Camper, and A.F. Seasholtz Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice Proc. Natl Acad. Sci. USA 96 1999 11595 11600
30. J. Kehne, and S. De Lombaert Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders Curr. Drug Targets CNS Neurol. Disord. 1 2002 467 493
31. L.G. Kirby, K.C. Rice, and R.J. Valentino Effects of corticotropin- releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus Neuropsychopharmacology 22 2000 148 162
32. T. Kishimoto, J. Radulovic, M. Radulovic, C.R. Lin, C. Schrick, F. Hooshmand, O. Hermanson, M.G. Rosenfeld, and J. Spiess Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 Nat. Genet. 24 2000 415 419
33. S. Lelas, H. Wong, Y.W. Li, K.L. Heman, K.A. Ward, K.L. Zeller, K.K. Sieracki, J.L. Polino, H.E. Godonis, S.X. Ren, X.X. Yan, S.P. Arneric, D.W. Robertson, P.R. Hartig, S. Grossman, G.L. Trainor, R.A. Taub, R. Zaczek, P.J. Gilligan, and J.F. McElroy Anxiolytic-like effects of the corticotropin- releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2- methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats J. Pharmacol. Exp. Ther. 309 2004 293 302
34. K. Lewis, C. Li, M.H. Perrin, A. Blount, K. Kunitake, C. Donaldson, J. Vaughan, T.M. Reyes, J. Gulyas, W. Fischer, L. Bilezikjian, J. Rivier, P.E. Sawchenko, and W.W. Vale Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor Proc. Natl Acad. Sci. USA 98 2001 7570 7575
35. T.W. Lovenberg, D.T. Chalmers, C. Liu, and E.B. De Souza CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues Endocrinology 136 1995 4139 4142
36. I. Lucki The forced swim test as a model for core and component behavioral effects of antidepressant drugs Behav. Pharmacol. 8 1997 523 532
37. J. Lundkvist, Z. Chai, R. Teheranian, H. Hasanvan, T. Bartfai, F. Jenck, U. Widmer, and J.L. Moreau A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity Eur. J. Pharmacol. 309 1996 195 200
38. C.M. Maciag, G. Dent, P. Gilligan, L. He, K. Dowling, T. Ko, S. Levine, and M.A. Smith Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation Neuropsychopharmacology 26 2002 574 582
39. R.S. Mansbach, E.N. Brooks, and Y.L. Chen Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist Eur. J. Pharmacol. 323 1997 21 26
40. M.J. Millan, M. Brocco, A. Gobert, G. Dorey, P. Casara, and A. Dekeyne Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent Neuropsychopharmacology 25 2001 585 600
41. P. Montecucchi, and A. Henschen Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei Int. J. Pept. Protein Res. 18 1981 113 120
42. M.B. Muller, S. Zimmermann, I. Sillaber, T.P. Hagemeyer, J.M. Deussing, P. Timpl, M.S. Kormann, S.K. Droste, R. Kuhn, J.M. Reul, F. Holsboer, and W. Wurst Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress Nat. Neurosci. 6 2003 1100 1107
43. D.M. Nielsen, G.J. Carey, and L.H. Gold Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice Eur. J. Pharmacol. 499 2004 135 146
44. S. Okuyama, S. Chaki, N. Kawashima, Y. Suzuki, S. Ogawa, A. Nakazato, T. Kumagai, T. Okubo, and K. Tomisawa Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001 J. Pharmacol. Exp. Ther. 289 1999 926 935
45. D.H. Overstreet, and G. Griebel Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression Eur. J. Pharmacol. 497 2004 49 53
46. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
47. E. Potter, S. Sutton, C. Donaldson, R. Chen, M. Perrin, K. Lewis, P.E. Sawchenko, and W. Vale Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary Proc. Natl Acad. Sci. USA 91 1994 8777 8781
48. M.L. Price, and I. Lucki Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor J. Neurosci. 21 2001 2833 2841
49. M.L. Price, A.L. Curtis, L.G. Kirby, R.J. Valentino, and I. Lucki Effects of corticotropin-releasing factor on brain serotonergic activity Neuropsychopharmacology 18 1998 492 502
50. M.L. Price, L.G. Kirby, R.J. Valentino, and I. Lucki Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming Psychopharmacology 162 2002 406 414
51. J. Radulovic, A. Rühmann, T. Liepold, and J. Spiess Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2 J. Neurosci. 19 1999 5016 5025
52. J.M. Reul, and F. Holsboer Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression Curr. Opin. Pharmacol. 2 2002 23 33
53. T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale, and P.E. Sawchenko Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors Proc. Natl Acad. Sci. USA 98 2001 2843 2848
54. A. Rühmann, I. Bonk, C.J.R. Lin, M.G. Rosenfeld, and J. Spiess Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2 beta-selective antisauvagine-30 Proc. Natl Acad. Sci. USA 95 1998 15264 15269
55. P.E. Sawchenko, and L.W. Swanson Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain Fed. Proc. 44 1985 221 227
56. D.W. Schulz, R.S. Mansbach, J. Sprouse, J.P. Braselton, J. Collins, M. Corman, A. Dunaiskis, S. Faraci, A.W. Schmidt, T. Seeger, P. Seymour, F.D. Tingley 3rd, E.N. Winston, Y.L. Chen, and J. Heym CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors Proc. Natl Acad. Sci. USA 93 1996 10477 10482
57. Y. Shaham, S. Erb, S. Leung, Y. Buczek, and J. Stewart CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats Psychopharmacology (Berl.) 137 1998 184 190
58. T. Skutella, J.C. Probst, U. Renner, F. Holsboer, and C. Behl Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety Neuroscience 85 1998 795 805
59. G. Smith, J.-M. Aubry, F. Dellu, A. Contarino, L. Bilezikjian, L. Gold, R. Chen, Y. Marchuk, C. Hauser, C. Bentley, P. Sawchenko, G. Koob, W. Vale, and K.-F. Lee Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development Neuron 20 1998 1093 1102
60. J. Spiess, J. Rivier, C. Rivier, and W.W. Vale Primary structure of corticotropin-releasing factor from ovine hypothalamus Proc. Natl Acad. Sci. USA 78 1981 6517 6521
61. M.P. Stenzel-Poore, S.C. Heinrichs, S. Rivest, G.F. Koob, and W.W. Vale Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior J. Neurosci. 14 1994 2579 2584
62. L.W. Swanson, and W.M. Cowan An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat J. Comp. Neurol. 172 1977 49 84
63. L.W. Swanson, P.E. Sawchenko, J. Rivier, and W.W. Vale Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study Neuroendocrinology 36 1983 165 186
64. K. Takamori, N. Kawashima, S. Chaki, A. Nakazato, and K. Kameo Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats Life Sci. 69 2001 1241 1248
65. H. Tezval, O. Jahn, C. Todorovic, A. Sasse, K. Eckart, and J. Spiess Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model Proc. Natl Acad. Sci. USA 101 2004 9468 9473
66. E. Thomas, E. Yadin, and C.E. Strickland Septal unit activity during classical conditioning: a regional comparison Brain Res. 547 1991 303 308
67. E. Thomas, L. Pernar, I. Lucki, and R.J. Valentino Corticotropin- releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons Brain Res. 960 2003 201 208
68. P. Timpl, R. Spanagel, I. Sillaber, A. Kresse, J. Reul, G.K. Stalla, V. Blanquet, T. Steckler, F. Holsboer, and W. Wurst Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 Nat. Genet. 19 1998 162 166
69. I.J.A. Urban, A. Ontskul, G. Croiset, Y. Cheng, and D.A. De Wied Long-lasting increase and decrease in synaptic excitability in the rat lateral septum are associated with high and low shuttle box performance, respectively Behav. Brain Res. 68 1995 173 183
70. W.W. Vale, J. Spiess, C. Rivier, and J. Rivier Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin Science 213 1981 1394 1397
71. R.J. Valentino, L. Liouterman, and E.J. Van Bockstaele Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus J. Comp. Neurol. 435 2001 450 463
72. K. Van Pett, V. Viau, J.C. Bittencourt, R.K. Chan, H.Y. Li, C. Arias, G.S. Prins, M. Perrin, W. Vale, and P.E. Sawchenko Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse J. Comp. Neurol. 428 2000 191 212
73. J. Vaughan, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, S. Sutton, R. Chan, A.V. Turnbull, D. Lovejoy, C. Rivier, J. Rivier, P.E. Sawchenko, and W.W. Vale Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor Nature 378 1995 287 292
74. R.M. Vouimba, R. Garcia, and R. Jaffard Pretraining tetanic fimbrial stimulation impairs the expression but not the acquisition of contextual fear conditioning in mice Neuroscience 93 1999 869 876
75. A.W. Zobel, T. Nickel, H.E. Kunzel, N. Ackl, A. Sonntag, M. Ising, and F. Holsboer Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated J. Psychiatr. Res. 34 2000 171 181
76. E.P. Zorrilla, G.R. Valdez, J. Nozulak, G.F. Koob, and A. Markou Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat Brain Res. 952 2002 188 199